礼来公司 - 肥胖药物：领域拓展-未来走向何方

November 23, 2025 11:31 PM GMT Eli Lilly & Co. | North America Obesity Medications: The Broadening – Where do we go from here? | What's Changed | | | | --- | --- | --- | | Eli Lilly & Co. (LLY.N) | From | To | | Price Target | $1,171.00 | $1,290.00 | Earlier this year we outlined our views on "The Broadening" of the GLP-1 market driven by a number of factors, which are playing out. We refresh our LLY model to incorporate these recent developments, in addition to insights from our physician survey; our PT go ...